US Stock MarketDetailed Quotes

Apogee Therapeutics (APGE)

Watchlist
  • 79.860
  • -2.050-2.50%
Close Jan 22 16:00 ET
  • 79.630
  • -0.230-0.29%
Pre 04:24 ET
5.46BMarket Cap-18.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apogee Therapeutics (APGE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-128.96%-171.17M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.3M
-199.67%-31.64M
-355.11%-74.76M
-223.80%-29.75M
Net income from continuing operations
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
Depreciation and amortization
745.83%406K
1,008.33%399K
613.79%207K
--189K
--76K
--48K
--36K
--29K
--0
--0
Other non cash items
142.89%940K
228.93%921K
222.18%857K
1,847.13%1.69M
--761K
--387K
--280K
--266K
-99.24%87K
----
Change In working capital
-122.47%-837K
-543.39%-6.84M
-124.60%-2.95M
-132.79%-2M
-336.16%-5.96M
1,290.10%3.73M
-51.84%1.54M
-289.19%-1.31M
-37.80%6.11M
19.36%2.52M
-Change in prepaid assets
25.03%-2.11M
-109.15%-2.54M
161.22%895K
-118.31%-6.08M
-196.60%-596K
-95.34%-2.81M
36.82%-1.21M
-3,222.73%-1.46M
-1,587.88%-2.79M
473.94%617K
-Change in payables and accrued expense
-64.14%2.44M
-159.07%-1.81M
873.54%4.01M
-43.67%5.22M
-322.04%-5.07M
505.24%6.81M
-40.14%3.07M
-44.17%412K
-7.14%9.27M
0.18%2.28M
-Change in other current assets
-293.48%-181K
-2,165.67%-1.52M
---6.84M
9.35%-97K
114.95%16K
---46K
---67K
--0
---107K
---107K
-Change in other current liabilities
-333.19%-992K
-297.95%-971K
-285.55%-1.01M
-287.04%-1.05M
-14.44%-309K
---229K
---244K
---263K
---270K
---270K
Cash from discontinued investing activities
Operating cash flow
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-128.96%-171.17M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.3M
-199.67%-31.64M
-355.11%-74.76M
-223.80%-29.75M
Investing cash flow
Cash flow from continuing investing activities
112.26%17.95M
152.54%78.13M
125.09%12.98M
-9.69%-300.46M
216.82%46.37M
37.50%-146.38M
-148.71M
-51.74M
-273.91M
-39.69M
Net PPE purchase and sale
--0
-1,405.88%-768K
-1,129.91%-4.32M
-589.82%-1.15M
100.60%1K
---751K
---51K
---351K
---167K
---167K
Net investment purchase and sale
112.32%17.95M
153.07%78.89M
133.66%17.3M
-9.34%-299.31M
217.31%46.37M
37.82%-145.63M
---148.66M
---51.39M
---273.74M
---39.53M
Cash from discontinued investing activities
Investing cash flow
112.26%17.95M
152.54%78.13M
125.09%12.98M
-9.69%-300.46M
216.82%46.37M
37.50%-146.38M
---148.71M
---51.74M
---273.91M
---39.69M
Financing cash flow
Cash flow from continuing financing activities
5,053.52%19.74M
886.67%1.18M
-99.86%622K
56.98%495.11M
20,924.41%44.36M
-99.88%383K
91.15%-150K
450.52M
87.38%315.39M
-100.13%-213K
Net common stock issuance
--19.38M
--0
--0
56.47%493.48M
20,535.68%43.53M
--0
---541K
--450.5M
--315.39M
97.83%-213K
Proceeds from stock option exercised by employees
-7.05%356K
201.79%1.18M
2,491.67%622K
--1.63M
--828K
--383K
--391K
--24K
--0
--0
Cash from discontinued financing activities
Financing cash flow
5,053.52%19.74M
886.67%1.18M
-99.86%622K
56.98%495.11M
20,924.41%44.36M
-99.88%383K
91.15%-150K
--450.52M
87.38%315.39M
-100.13%-213K
Net cash flow
Beginning cash position
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
-21.91%118.61M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
-21.91%118.61M
--151.89M
7,188.77%188.27M
Current changes in cash
91.21%-16.57M
109.70%17.28M
-109.50%-34.87M
170.53%23.47M
133.03%23.01M
-398.29%-188.52M
-995.41%-178.16M
3,577.70%367.14M
-121.91%-33.28M
-146.65%-69.66M
End cash Position
-9.37%107.91M
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
19.79%142.08M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
-21.91%118.61M
-21.91%118.61M
Free cash flow
-25.37%-54.26M
-113.95%-62.8M
-65.05%-52.79M
-129.99%-172.33M
-126.31%-67.71M
-117.68%-43.28M
-101.45%-29.35M
-202.99%-31.99M
-356.13%-74.93M
-225.62%-29.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -27.59%-54.26M-111.70%-62.03M-53.23%-48.48M-128.96%-171.17M-127.58%-67.71M-113.90%-42.52M-101.10%-29.3M-199.67%-31.64M-355.11%-74.76M-223.80%-29.75M
Net income from continuing operations -32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M
Depreciation and amortization 745.83%406K1,008.33%399K613.79%207K--189K--76K--48K--36K--29K--0--0
Other non cash items 142.89%940K228.93%921K222.18%857K1,847.13%1.69M--761K--387K--280K--266K-99.24%87K----
Change In working capital -122.47%-837K-543.39%-6.84M-124.60%-2.95M-132.79%-2M-336.16%-5.96M1,290.10%3.73M-51.84%1.54M-289.19%-1.31M-37.80%6.11M19.36%2.52M
-Change in prepaid assets 25.03%-2.11M-109.15%-2.54M161.22%895K-118.31%-6.08M-196.60%-596K-95.34%-2.81M36.82%-1.21M-3,222.73%-1.46M-1,587.88%-2.79M473.94%617K
-Change in payables and accrued expense -64.14%2.44M-159.07%-1.81M873.54%4.01M-43.67%5.22M-322.04%-5.07M505.24%6.81M-40.14%3.07M-44.17%412K-7.14%9.27M0.18%2.28M
-Change in other current assets -293.48%-181K-2,165.67%-1.52M---6.84M9.35%-97K114.95%16K---46K---67K--0---107K---107K
-Change in other current liabilities -333.19%-992K-297.95%-971K-285.55%-1.01M-287.04%-1.05M-14.44%-309K---229K---244K---263K---270K---270K
Cash from discontinued investing activities
Operating cash flow -27.59%-54.26M-111.70%-62.03M-53.23%-48.48M-128.96%-171.17M-127.58%-67.71M-113.90%-42.52M-101.10%-29.3M-199.67%-31.64M-355.11%-74.76M-223.80%-29.75M
Investing cash flow
Cash flow from continuing investing activities 112.26%17.95M152.54%78.13M125.09%12.98M-9.69%-300.46M216.82%46.37M37.50%-146.38M-148.71M-51.74M-273.91M-39.69M
Net PPE purchase and sale --0-1,405.88%-768K-1,129.91%-4.32M-589.82%-1.15M100.60%1K---751K---51K---351K---167K---167K
Net investment purchase and sale 112.32%17.95M153.07%78.89M133.66%17.3M-9.34%-299.31M217.31%46.37M37.82%-145.63M---148.66M---51.39M---273.74M---39.53M
Cash from discontinued investing activities
Investing cash flow 112.26%17.95M152.54%78.13M125.09%12.98M-9.69%-300.46M216.82%46.37M37.50%-146.38M---148.71M---51.74M---273.91M---39.69M
Financing cash flow
Cash flow from continuing financing activities 5,053.52%19.74M886.67%1.18M-99.86%622K56.98%495.11M20,924.41%44.36M-99.88%383K91.15%-150K450.52M87.38%315.39M-100.13%-213K
Net common stock issuance --19.38M--0--056.47%493.48M20,535.68%43.53M--0---541K--450.5M--315.39M97.83%-213K
Proceeds from stock option exercised by employees -7.05%356K201.79%1.18M2,491.67%622K--1.63M--828K--383K--391K--24K--0--0
Cash from discontinued financing activities
Financing cash flow 5,053.52%19.74M886.67%1.18M-99.86%622K56.98%495.11M20,924.41%44.36M-99.88%383K91.15%-150K--450.52M87.38%315.39M-100.13%-213K
Net cash flow
Beginning cash position -59.53%124.49M-77.93%107.21M19.79%142.08M-21.91%118.61M-36.75%119.07M145.94%307.59M243.69%485.75M-21.91%118.61M--151.89M7,188.77%188.27M
Current changes in cash 91.21%-16.57M109.70%17.28M-109.50%-34.87M170.53%23.47M133.03%23.01M-398.29%-188.52M-995.41%-178.16M3,577.70%367.14M-121.91%-33.28M-146.65%-69.66M
End cash Position -9.37%107.91M-59.53%124.49M-77.93%107.21M19.79%142.08M19.79%142.08M-36.75%119.07M145.94%307.59M243.69%485.75M-21.91%118.61M-21.91%118.61M
Free cash flow -25.37%-54.26M-113.95%-62.8M-65.05%-52.79M-129.99%-172.33M-126.31%-67.71M-117.68%-43.28M-101.45%-29.35M-202.99%-31.99M-356.13%-74.93M-225.62%-29.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -